Bruker to Host Investor Day on June 15th, 2023
31 Maio 2023 - 5:33PM
Business Wire
Bruker Corporation (Nasdaq: BRKR) today announced the Company
will host an Investor Day on June 15th, 2023, starting at 10:00 AM
EDT, at Bruker’s Headquarters located at 40 Manning Road,
Billerica, MA, with the live webcast starting at 11:00 AM EDT.
Bruker’s 2023 Investor Day will provide a deeper look into the
Company’s strategies and Project Accelerate 2.0 initiatives, with a
particular focus on the two key themes of Proteomics and Spatial
Biology. Bruker also intends to communicate its outlook for
medium-term financial performance at the event. The event will
begin with demo lab tours highlighting the capabilities of our
timsTOF life science mass spectrometry, NMR, and Spatial Biology
technologies, followed by management presentations and videos, and
concluding with a live Q&A session.
The management presentations and Q&A portions of the
Investor Day will be webcast live, beginning at approximately 11:00
am EDT, and concluding at approximately 1:30 pm EDT. A link to the
Investor Day webcast will be available in the Events &
Presentations section of the Company’s Investor Relations website
at https://ir.bruker.com. A replay will be available on Bruker’s
Investor Relations website after the conclusion of the event. The
demo lab tours from 10:00am EDT to 11:00 am EDT will not be
webcast.
For more information regarding in-person attendance, please
reach out to our Investor Relations team at
Investor.Relations@bruker.com.
About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries
and develop new applications that improve the quality of human
life. Bruker’s high performance scientific instruments and high
value analytical and diagnostic solutions enable scientists to
explore life and materials at molecular, cellular, and microscopic
levels. In close cooperation with our customers, Bruker is enabling
innovation, improved productivity, and customer success in
life-science molecular and cell biology research, in applied and
pharma applications, in microscopy and nanoanalysis, as well as in
industrial research, semiconductor metrology and cleantech
applications. Bruker offers differentiated, high-value life science
and diagnostics systems and solutions in preclinical imaging,
clinical phenomics research, proteomics and multiomics, spatial and
single-cell biology, functional structural and condensate biology,
as well as in clinical microbiology and molecular diagnostics. For
more information, please visit: www.bruker.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230531005984/en/
Justin Ward Sr. Director, Investor Relations & Corporate
Development Bruker Corporation T: +1 (978) 313-5800 E:
Investor.Relations@bruker.com
Bruker (NASDAQ:BRKR)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Bruker (NASDAQ:BRKR)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024